Summit Therapeutics SMMT
NASDAQ SMMT
$17.60 +0.48 (+2.77%)
As of: Sep 4, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Property, Plant & Equipment (Net) (2017 - 2026)

Analysis

Summit Therapeutics (SMMT) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Summit Therapeutics 13.67 Bn 12.98 Bn - 1.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.78 Mn
Mar 31, 2026 1.66 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 810,000.00
Jun 30, 2025 690,000.00
Mar 31, 2025 652,000.00
Dec 31, 2024 254,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 223,000.00
Mar 31, 2024 181,000.00
Dec 31, 2023 204,000.00
Sep 30, 2023 229,000.00
Jun 30, 2023 225,000.00
Mar 31, 2023 412,000.00
Dec 31, 2022 906,000.00
Sep 30, 2022 930,000.00
Jun 30, 2022 1.10 Mn
Mar 31, 2022 965,000.00
Dec 31, 2021 694,000.00
Sep 30, 2021 656,000.00